Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ · Healthcare
Insight Molecular Diagnostics Inc. Total Liabilities 2020–2025
Insight Molecular Diagnostics Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Insight Molecular Diagnostics Inc. total liabilities as of December 31, 2025: 57.2M, a 20.83% increase year-over-year.
- Insight Molecular Diagnostics Inc. total liabilities for 2025 were 57.2M, a 20.83% increase from 2024.
- Insight Molecular Diagnostics Inc. total liabilities for 2024 were 47.4M, a 3.94% decrease from 2023.
- Insight Molecular Diagnostics Inc. total liabilities for 2023 were 49.3M, a 18.51% decrease from 2022.
- Insight Molecular Diagnostics Inc. total liabilities for 2022 were 60.5M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Insight Molecular Diagnostics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $57 |
| 2024 | $47 |
| 2023 | $49 |
| 2022 | $60 |
| 2021 | $94 |
| 2020 | $22 |
Insight Molecular Diagnostics Inc. Total Liabilities — FAQ
Insight Molecular Diagnostics Inc. (IMDX) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMDX's total liabilities history?
The chart and table above show Insight Molecular Diagnostics Inc.'s total liabilities by year and by quarter, including the growth rate.